BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36443123)

  • 1. Re: Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. High-risk pathologic features based on presenting findings in advanced intraocular retinoblastoma: a multicenter, international data-sharing American Joint Committee on Cancer Study (Ophthalmology. 2022;129:923-932) and Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. Metastatic death based on presenting features and treatment for advanced intraocular retinoblastoma: a multicenter registry-based study. (Ophthalmology. 2022;129:933-945).
    Abramson DH; Shields CL
    Ophthalmology; 2023 Mar; 130(3):e11-e12. PubMed ID: 36443123
    [No Abstract]   [Full Text] [Related]  

  • 2. High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study.
    Tomar AS; Finger PT; Gallie B; Kivelä TT; Mallipatna A; Zhang C; Zhao J; Wilson MW; Brennan RC; Burges M; Kim J; Berry JL; Jubran R; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Volodin D; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català-Mora J; Correa-Llano G; Carreras E;
    Ophthalmology; 2022 Aug; 129(8):923-932. PubMed ID: 35436535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study.
    Tomar AS; Finger PT; Gallie B; Kivelä TT; Mallipatna A; Zhang C; Zhao J; Wilson MW; Brennan RC; Burges M; Kim J; Berry JL; Jubran R; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Volodin D; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català-Mora J; Correa-Llano G; Carreras E;
    Ophthalmology; 2022 Aug; 129(8):933-945. PubMed ID: 35500608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma: Part II: Treatment Success and Globe Salvage.
    Tomar AS; Finger PT; Gallie B; Mallipatna A; Kivelä TT; Zhang C; Zhao J; Wilson MW; Brenna RC; Burges M; Kim J; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català J; Correa-Llano G; Carreras E;
    Ophthalmology; 2020 Dec; 127(12):1733-1746. PubMed ID: 32526306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
    Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH
    JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma: Part I: Metastasis-Associated Mortality.
    Tomar AS; Finger PT; Gallie B; Mallipatna A; Kivelä TT; Zhang C; Zhao J; Wilson MW; Kim J; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Català J; Correa-Llano G;
    Ophthalmology; 2020 Dec; 127(12):1719-1732. PubMed ID: 32512116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PREDICTIVE VALUE OF TNM CLASSIFICATION, INTERNATIONAL CLASSIFICATION, AND REESE-ELLSWORTH STAGING OF RETINOBLASTOMA FOR THE LIKELIHOOD OF HIGH-RISK PATHOLOGIC FEATURES.
    Yousef YA; Al-Hussaini M; Mehyar M; Sultan I; Jaradat I; AlRawashdeh K; Khurma S; Deebajah R; Nawaiseh I
    Retina; 2015 Sep; 35(9):1883-9. PubMed ID: 25923953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral advanced (group D or E) intraocular retinoblastoma: outcomes in 72 Asian Indian patients.
    Kaliki S; Mittal P; Mohan S; Chattannavar G; Jajapuram SD; Mohamed A; Palkonda VAR
    Eye (Lond); 2019 Aug; 33(8):1297-1304. PubMed ID: 30932036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Retinoblastoma Treatment Outcomes: Association with National Income Level.
    Tomar AS; Finger PT; Gallie B; Kivelä TT; Mallipatna A; Zhang C; Zhao J; Wilson MW; Brenna RC; Burges M; Kim J; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català J; Correa-Llano G; Carreras E;
    Ophthalmology; 2021 May; 128(5):740-753. PubMed ID: 33007338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Status and role of ophthalmic pathology in ophthalmology].
    Xia R; Sun X
    Zhonghua Yan Ke Za Zhi; 1996 Nov; 32(6):403-4. PubMed ID: 9590804
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinicopathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastoma.
    Wilson MW; Qaddoumi I; Billups C; Haik BG; Rodriguez-Galindo C
    Br J Ophthalmol; 2011 Apr; 95(4):553-8. PubMed ID: 20693555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
    Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
    J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis.
    Suzuki S; Yamane T; Mohri M; Kaneko A
    Ophthalmology; 2011 Oct; 118(10):2081-7. PubMed ID: 21715012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country.
    Kashyap S; Sethi S; Meel R; Pushker N; Sen S; Bajaj MS; Chandra M; Ghose S
    Arch Pathol Lab Med; 2012 Feb; 136(2):190-3. PubMed ID: 22288967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC).
    Alkatan HM; AlQahtani FS; Maktabi AM
    Int Ophthalmol; 2020 Jul; 40(7):1739-1747. PubMed ID: 32193778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
    Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
    Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC.
    Abramson DH; Fabius AW; Issa R; Francis JH; Marr BP; Dunkel IJ; Gobin YP
    PLoS One; 2015; 10(12):e0145436. PubMed ID: 26709699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Insurance, Race, and Ethnicity with Pathologic Risk in a Controlled Retinoblastoma Cohort: A Children's Oncology Group Study.
    Green AL; Chintagumpala M; Krailo M; Langholz B; Albert D; Eagle R; Cockburn M; Chevez-Barrios P; Rodriguez-Galindo C
    Ophthalmology; 2016 Aug; 123(8):1817-1823. PubMed ID: 27262763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review.
    Ong SJ; Chao AN; Wong HF; Liou KL; Kao LY
    Jpn J Ophthalmol; 2015 Mar; 59(2):109-17. PubMed ID: 25465196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
    Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.